Half of metastatic lung cancer patients never receive treatment despite modern advances

Approximately 50,000 metastatic lung cancer patients annually in the U.S. forgo potentially life-extending treatments, with 40% dying within 90 days of diagnosis.

Each year, roughly fifty thousand Americans diagnosed with advanced lung cancer never receive treatment — not because medicine has failed to find answers, but because the answers are not reaching them. A study published in JAMA Oncology by researchers at MUSC Hollings Cancer Center reveals that the gap lies not in the oncology clinic, where treatment rates are high, but in the long and often broken path that leads there. It is a story about the distance between what medicine knows and what medicine does — a distance measured, in this case, in human lives.

Half of metastatic lung cancer patients never receive treatment despite modern advances

Cobertura Relacionada

Recibe The Register en tu bandeja